Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer

Triple-negative breast cancer (TNBC), defined as loss of estrogen, progesterone, and Her2 receptors, is a subtype of highly aggressive breast cancer with worse prognosis and poor survival rate. Macrophage migration inhibitory factor (MIF) is a pleiotropic pro-inflammatory cytokine aberrantly express...

Descripción completa

Detalles Bibliográficos
Autores principales: Charan, Manish, Das, Subhadip, Mishra, Sanjay, Chatterjee, Nabanita, Varikuti, Sanjay, Kaul, Kirti, Misri, Swati, Ahirwar, Dinesh K., Satoskar, Abhay R., Ganju, Ramesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498597/
https://www.ncbi.nlm.nih.gov/pubmed/32943608
http://dx.doi.org/10.1038/s41419-020-02992-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498597/
https://www.ncbi.nlm.nih.gov/pubmed/32943608
http://dx.doi.org/10.1038/s41419-020-02992-y

Ejemplares similares